arrow_back Back to App

Lower Drug Costs for Families: Inflation Rebate Expansion

This bill aims to reduce drug costs by extending inflation rebates to drugs sold in the commercial market. This means drug manufacturers will have to pay back money if their drug prices rise faster than inflation, potentially leading to lower costs for patients. These changes could help ease the financial burden of purchasing medications.
Key points
Drug manufacturers will be required to pay rebates if their drug prices increase too quickly, even for drugs sold outside government programs.
The base year for calculating rebates has been changed, which could increase the amounts manufacturers owe and potentially lower drug prices.
New rules will take effect from January 1, 2026, for some drugs and from October 1, 2025, for others.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_2554
Sponsor: Rep. Horsford, Steven [D-NV-4]
Process start date: 2025-04-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Lower Drug Costs for Families Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2554.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-01.

What are the main provisions?

Key points include:

  • Drug manufacturers will be required to pay rebates if their drug prices increase too quickly, even for drugs sold outside government programs.
  • The base year for calculating rebates has been changed, which could increase the amounts manufacturers owe and potentially lower drug prices.
  • New rules will take effect from January 1, 2026, for some drugs and from October 1, 2025, for others.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Horsford, Steven [D-NV-4].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health